132Tip HCB-ONC001 ELPIS TRIAL: Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-Risk HER2-positive Breast Cancer with High HER2 Addiction and a Complete Response Following Standard Anti-Her2-based Neoadjuvant Therapy
ANNALS OF ONCOLOGY(2022)
Key words
Neoadjuvant Therapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined